Should You Be Tempted To ‘Sell’ Emergent Biosolutions (EBS) Stock?

This post was originally published on this site

I am incredibly lucky.

As a long-time tech stock analyst at The Motley Fool, every day I wake up and get the chance help everyday people identify and profit from some of the world’s most promising investment opportunities.

And it’s times of uncertainty and confusion that really open the doors to some of the best opportunities available to investors like you and me.

I’m writing you today to talk about something I believe will change the way you invest forever.

It’s hard to believe, but 2021 marks the 28-year anniversary of the founding of The Motley Fool by those two brothers, David and Tom Gardner.

It’s truly amazing that Tom and David were able to go from publishing an investment newsletter for 300 or so subscribers out of the shed behind David’s house…

To serving millions of hardworking investors like you around the globe from offices in far-flung countries like Australia, Germany, the United Kingdom, Hong Kong, and Japan…

All while navigating the dot.com bubble, the Housing Crisis, and the current environment.

David and Tom have put together a heck of a run. And since I have the luxury of working with them, I know what they’re most proud of is their ability to consistently lead investors to some of the most life-changing investment returns the market has ever seen. I’m talking, of course, about companies like:

  • Amazon (up 22,559%)
  • Netflix (up 32,188%)
  • Nvidia (up 5,718%)
  • Baidu (up 1,868%)
  • Salesforce.com (up 3,632%)

Those are actual investment recommendations The Motley Fool has shared with our investing community over the years – and the list goes on!

And that’s why I’m writing this today.

Because this track record, combined with a historically very profitable stock buy signal, could change the way you invest forever.

And that buy signal is flashing right now.

Click to continue reading…